Dutch HTA Calls For “Socially Acceptable” Price For Gene Editing Therapy Casgevy

 
• By Francesca Bruce
  
Dutch HTA calls for lower drug prices. (Shutterstock)

More from Health Technology Assessment

More from Market Access